ASTH · NASDAQ · Medical - Care Facilities

Astrana Health (ASTH)

Connects risk-bearing physician networks, care delivery, and operating technology for value-based healthcare.

$35.11
After hours0.00 (0.00%)
At close$35.11(+4.65%)
Loading prices…

Astrana Health, Inc.ASTH
Health Care

Organizes risk-bearing physician networks, operates care sites, and supplies clinical and administrative technology through Care Partners, Care Delivery, and Care Enablement. Revenue comes mainly from capitated health-plan contracts, making medical-cost control, payer relationships, and government healthcare rules central to the model.

Coordinates value-based care through three connected businesses. Care Partners organizes independent practice associations, accountable care organizations, and other risk-bearing provider networks; Care Delivery runs primary, specialty, ancillary, and hospital services; Care Enablement supplies clinical, operational, financial, technology, and management infrastructure to affiliated and third-party providers.

Operates across several U.S. markets while remaining concentrated in California, serving Medicare, Medicaid, commercial, and exchange-insured populations. The integrated model links contracted physicians, owned care sites, and shared data systems so providers can manage care across settings.

Earns most revenue from capitation, supplemented by risk settlements, management and software fees, and fee-for-service care. Care Partners bears varying levels of medical-cost risk; results also depend on a concentrated group of health-plan payers and federal and state healthcare rules.

Company facts

CEOBrandon K. Sim
ListedDec 8, 2017
ExchangeNASDAQ
HeadquartersAlhambra, CA
CountryUnited States
Employees3,000
CIK0001083446
ISINUS03763A2078

Market cap$1.66B
EPS (ttm)$0.8175
P/E (ttm)41.04
ROE5.1%
P/B2.00
P/S0.4327
Dividend yieldDiv yield
Beta0.59vs XLV 0.41

Price target$53.00+50.1%Average of 10 analysts
ConsensusBuy10 of 10 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Sep 15, 2026OppenheimerInitiate
Rating: Target:
Rating: OutperformTarget: $53
Aug 10, 2026Truist FinancialTarget
Target: $47
Target: $55
Aug 7, 2026BarclaysReiterate
Rating: Target: $50
Rating: OverweightTarget: $53
Jul 14, 2026BTIGReiterate
Rating: Target: $40
Rating: BuyTarget: $65
May 26, 2026BarclaysUpgrade
Rating: Equal WeightTarget: $37
Rating: OverweightTarget: $50

Next report
Nov 5, 26
in 44 days
EPS estimate
$0.44
Revenue estimate
$1.02B
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.15$0.14$0.19$0.01$0.12$0.30$0.40Pending
Estimate$0.22$0.23$0.36$0.47$0.15$0.29$0.34$0.44
Surprise−168.2%−39.1%−47.2%−97.9%−20.0%+3.4%+19.1%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$665.2M$620.4M$654.8M$956.0M$950.5M$965.1M$972.5MPending
Estimate$617.2M$630.7M$943.7M$930.5M$930.4M$949.2M$982.2M$1.02B
Surprise+7.8%−1.6%−30.6%+2.7%+2.2%+1.7%−1.0%
Estimate$0.44
ReportedDue Nov 5, 2026
Estimate$1.02B
ReportedDue Nov 5, 2026
View details

Debt to equity118.00%
Current ratio122.90%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$478.7M$665.2M$620.4M$654.8M$956.0M$950.5M$965.1M$972.5M
Net income$16.1M−$7.0M$6.7M$9.4M$373.0K$6.0M$14.4M$19.7M
Net margin3.4%0.0%1.1%1.4%0.0%0.6%1.5%2.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$28.4M$720.0K$20.6M$20.3M$19.2M$18.4M$28.5M$34.3M
YoY growth−27.3%Turned profit−31.7%−32.3%−32.4%+2,454.9%+38.6%+68.7%

Balance sheet, Jun 30, 2026Cash & short-term investments $400.8M · Total debt $979.4M · Total assets $2.28B · Shareholders' equity $830.2M

Revenue
$972.5M
Operating income
$34.3M
Net income
$19.7M
View details

No dividends on record.

Insiders34.29%17.00M shares
13 holders · as of Sep 17, 2026
Strategic holders24.94%12.37M shares
2 holders · as of Apr 17, 2025
Other40.77%20.22M shares
remainder

49.58M company shares as of Aug 23, 2026 · holders as of their latest filing

Two share counts disagree (55.72M in the company's Sep 22, 2026 report, 49.58M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Thomas S. LamInsiderdirector
15.59%7.73Mfiled Apr 8, 2026
Kenneth T. SimInsiderdirector, officer: Executive Chairman
14.96%7.42Mfiled Apr 8, 2026
BlackRock, Inc.Strategic
12.57%6.23Mfiled Apr 17, 2025
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp1,2Strategic10 percent owner
12.37%6.13Mfiled Feb 18, 2025
Vanguard Portfolio ManagementInstitution
5.34%2.65Mfiled Jul 31, 2026
  1. ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp's transaction reports restate only vehicles that traded; the 2025 ownership statement (6.13M) is used instead.
  2. ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp reports a block also reported by BlackRock, Inc.; it is counted once, under BlackRock, Inc.

Insider tradesForm 4

No open-market trades in the last 12 months.

View details

  • UnitedHealth Group

    Largest U.S. physician employer; vertically integrated MA insurer-provider

  • Agilon Health

    Full-risk MA physician enablement platform; ~$5.9B revenue, 625K members

  • Privia Health

    National physician enablement platform with MSO, ACO, and primary care focus

  • Alignment Healthcare

    Medicare Advantage plan operator with integrated care model across 5 states

  • Humana

    National MA insurer building the largest senior primary care clinic chain

  • Evolent

    Specialty cost manager for payers; full-risk oncology and cardiology at scale.

CompareAfter hours

CompanyPriceChange
Astrana Health$35.110.00%$1.66B41.021.20.4+48.5%
UnitedHealth Group$373.18+0.08%$342.88B24.317.50.8+0.4%
Agilon Health$86.84−0.07%$1.47B0.2+7.2%
Privia Health$19.460.00%$2.46B90.150.61.0+21.4%
Alignment Healthcare$7.990.00%$1.73B44.628.90.4+31.6%
Humana$372.00−0.03%$45.39B35.930.20.3+26.2%
Evolent$3.73−1.58%$415.1M11.30.2+46.9%
Median40.228.90.3+23.8%